KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

West Pharmaceutical Services (WST) Shares Outstanding (Weighted Average) (2016 - 2026)

West Pharmaceutical Services has reported Shares Outstanding (Weighted Average) over the past 17 years, most recently at $72.0 million for Q1 2026.

  • Quarterly Shares Outstanding (Weighted Average) fell 0.69% to $72.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $72.0 million through Mar 2026, down 0.69% year-over-year, with the annual reading at $72.3 million for FY2025, 0.96% down from the prior year.
  • Shares Outstanding (Weighted Average) was $72.0 million for Q1 2026 at West Pharmaceutical Services, roughly flat from $72.3 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $74.5 million in Q1 2023 and troughed at $72.0 million in Q1 2026.
  • The 5-year median for Shares Outstanding (Weighted Average) is $73.5 million (2024), against an average of $73.4 million.
  • Biggest five-year swings in Shares Outstanding (Weighted Average): increased 0.68% in 2022 and later decreased 2.02% in 2024.
  • Tracing WST's Shares Outstanding (Weighted Average) over 5 years: stood at $74.4 million in 2022, then decreased by 0.13% to $74.3 million in 2023, then dropped by 1.75% to $73.0 million in 2024, then decreased by 0.96% to $72.3 million in 2025, then decreased by 0.41% to $72.0 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $72.0 million, $72.3 million, and $72.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.